RT Journal Article
SR Electronic
T1 Geospatial precision simulations of community confined human interactions during SARS-CoV-2 transmission reveals bimodal intervention outcomes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.03.20089235
DO 10.1101/2020.05.03.20089235
A1 Goldenbogen, B
A1 Adler, SO
A1 Bodeit, O
A1 Wodke, JAH
A1 Korman, A
A1 Bonn, L
A1 Escalera-Fanjul, X
A1 Haffner, JEL
A1 Karnetzki, M
A1 Krantz, M
A1 Maintz, I
A1 Mallis, L
A1 Moran Torres, RU
A1 Prawitz, H
A1 Segelitz, PS
A1 Seeger, M
A1 Linding, R
A1 Klipp, E
YR 2020
UL http://medrxiv.org/content/early/2020/05/27/2020.05.03.20089235.abstract
AB Infectious disease outbreaks challenge societies by creating dynamic stochastic infection networks between human individuals in geospatial and demographical contexts. Minimizing human and socioeconomic costs of SARS-CoV-2 and future global pandemics requires data-driven and context-specific integrative modeling of detection-tracing, healthcare, and non-pharmaceutical interventions for decision-processes and reopening strategies. Traditional population-based epidemiological models cannot simulate temporal infection dynamics for individual human behavior in specific geolocations. We present an integrated geolocalized and demographically referenced spatio-temporal stochastic network- and agent-based model of COVID-19 dynamics for human encounters in real-world communities. Simulating intervention scenarios, we quantify effects of protection and identify the importance of early introduction of test-trace measures. Critically, we observe bimodality in SARS-CoV-2 infection dynamics so that the outcome of reopening can flip between good and poor outcomes stochastically. Furthermore, intervention effectiveness depends on strict execution and temporal control i.e. leaks can prevent successful outcomes. Schools are in many scenarios hubs for transmission, reopening scenarios are impacted by infection chain stochasticity and subsequent outbreaks do not always occur. This generalizable geospatial and individualized methodology is unique in precision and specificity compared to prior COVID-19 models [6, 16, 17, 19] and is applicable to scientifically guided decision processes for communities worldwide.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Deutsche Forschungsgemeinschaft (DFG: Cluster of Excellence MATH+, TRR 175) and by the German Ministry of Education and Research (BMBF, Liver Systems Medicine (LiSyM) network grant) and by the People Programme (Marie Skłodowska-Curie Actions) of the European Unions Horizon 2020 Programme under REA grant agreement no. 813979 (Secreters). Escalera-Fanjul X is supported with a postdoctoral grant from CONACYT (CVU 420248).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n.a.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code will be available shortly at https://tbp-klipp.science/GERDA/code/